Gamida for Life Breaking News UK's NICE Reverses Course on Immunocore's Kimmtrak for Advanced Uveal Melanoma Epsilogen Launches Phase Ib IgE Antibody Trial in Advanced Ovarian Cancer Novartis Pens $2.9B Deal With PTC Therapeutics for Huntington's Disease Drug Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint Merck, Moderna Vax Trial Starts Enrolling Lung Cancer Patients at McGill University Health Center Senti Biosciences Announces $37.6M PIPE Financing, Reports Early Data From Phase I CAR-NK Trial